AngioGenex Appoints New CEO to Direct Development of Anti-C

**Curis helping to treat cancer, neurological degenerative, kidney disorders, CUDC-101. Pathways, hedgehog, EGFR, Her2, Hsp90, Bcr-Abl/Src, CDK, BCL, MEK, VEGF, HDAC.**

Pathway 2 Curis Forum (Hedgehog and beyond) Forum Index » RSS Yahoo BIOTECH
Reply to topic
AngioGenex Appoints New CEO to Direct Development of Anti-C
RSS FEED


Joined: 05 Apr 2006
Posts: 19275
Post Posted: Tue Jun 10, 2008 10:26 am Reply with quote


AngioGenex Inc. a New York-based biotechnology company, and the leader in the field of Id targeted anti-angiogenic drugs, announced the appointment of William Garland PhD as Chief Executive Officer.

Read more...
View user's profileSend private message
AngioGenex Appoints New CEO to Direct Development of Anti-C
All times are GMT - 7 Hours  
Page 1 of 1  
  
  
Pathway 2 Curis Forum (Hedgehog and beyond) Forum Index » RSS Yahoo BIOTECH
 Reply to topic  
Forum Map
Site Map